[Leu31,Pro34]-Neuropeptide Y (porcine)
Cat. No. 1168
Alternative Name: [Leu31 , Pro34]-NPY (porcine)
Biological ActivityHigh affinity neuropeptide Y Y1 receptor agonist (Ki = 0.54 nM). Also shows affinity for Y5 receptors.
(Modifications: Tyr-36 = C-terminal amide)
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Data Sheet
Kask et al (1998) Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226. Br.J.Pharmacol. 124 1507. PMID: 9723965.
Michel et al (1998) XVI.International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol.Rev. 50 143. PMID: 9549761.
Bard et al (1995) Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J.Biol.Chem. 270 26762. PMID: 7592911.
Fuhlendorff et al (1990) [Leu31, Pro34]Neuropeptide Y: a specific Y1 receptor agonist. Proc.Natl.Acad.Sci.U.S.A. 87 182. PMID: 2153286.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses [Leu31,Pro34]-Neuropeptide Y (porcine) from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: [Leu31,Pro34]-Neuropeptide Y (porcine), supplier, NPY, Y1, receptor, agonist, Neuropeptide, Y, Receptors, [Leu31Pro34]-NeuropeptideY, (porcine), neuropeptides, Tocris Bioscience, NPY Receptor Agonist products
Find multiple products by catalog number
New Products in this Area
Endogenous calcitonin receptor agonist; inhibits bone resorptionSpexin
Potent GAL2/3 agonist; exhibits anxiolytic effects in vivoMM 54
Potent apelin receptor antagonistMSG 606
Potent human MC1 receptor antagonist; also MC3 and MC5 partial agonist
December 13 - 15, 2016